The Unethical Ties Between NIH Director, Bill Gates, mRNA Jabs, and Massive Profits

For nearly four years, the Informed Consent Action Network (ICAN) has been investigating the unscrupulous relationships between Dr. Anthony Fauci’s National Institute of Allergy and Infectious Diseases (NIAID), nestled within the National Institutes of Health (NIH) and Dr. Barney Graham, who was the Deputy Director of the Vaccine Research Center (VRC) and chief of the Viral Pathogenesis at the NIH during the pandemic. In highlighting the “clear conflict” between Dr. Graham’s financial interest and his role in developing safe and effective vaccines to treat SARS-CoV-2, ICAN reported on January 12, 2021, that Graham “stands to earn millions from the sales of the Moderna vaccine.” Of course, besides Anthony Fauci and his cronies, the pandemic had Bill Gates’ name all over it. Is he involved in this, too?

ICAN’s investigation into officials within the NIH working to develop COVID-19 vaccines is centered around the common-sense idea that when government officials profit from the sale of a product, there is cause for concern regarding their licensure and promotion of that product. Thus, given the obvious conflict between these officials’ personal interest in making a profit and their duty and obligation to ensure vaccines are safe, ICAN’s attorneys submitted several Freedom of Information Act (FOIA) requests to the NIH, the parent company of NIAID. One of those requests was for Barney Graham’s emails regarding COVID-19. When NIH failed to respond to those requests, ICAN sued the agency in federal court. In response to that lawsuit, NIH agreed to produce responsive documents on a rolling basis.

Throughout the production of Graham’s emails, the NIH has heavily redacted many of these documents. Why? Graham stands to make millions from the Moderna vaccine. Thus, there should be complete transparency. According to the NIH, the emails “contain staff advice, opinion, and recommendations…” The NIH insisted that other redacted documents contain “trade secrets and commercial or financial information that is privileged and confidential.” ICAN vowed to challenge the NIH’s inappropriate redactions to ensure transparency prevails, even if it “hurts their pocketbook.” ICAN reported:

“When taxpayer money is being used to develop this vaccine, nothing should be a secret from the public. Certainly not communications between public officials that stand to personally earn millions of dollars from the sale of this vaccine and are using taxpayer money to develop the vaccine!

ICAN does not believe the same government officials who stand to profit from the vaccine should be able to hide their “advice, opinion and recommendations” regarding [the] same or to argue that their emails are “confidential.”

A look back at Dr. Graham’s involvement in the “record-breaking sprint” to craft a “vaccine” against COVID-19 reveals that Moderna’s COVID-19 vaccine mRNA-1273 was built off the prior work of Graham, a former professor of microbiology and immunology at Vanderbilt University in Nashville, TN. Before the pandemic gripped the globe, Graham and other “intramural scientists” at NIAID were designing vaccines for several coronaviruses using a “promising, new platform based on messenger RNA (mRNA).” Characterizing the monumental shift in Dr. Graham’s focus when COVID-19 hit, the NIH Catalyst reported:

“Everything changed on a Saturday morning in early January. Chinese scientists had isolated a new coronavirus that was causing a serious epidemic in China’s Wuhan province and released its genetic sequence to the scientific community around the world. Barney Graham, director of the VRC’s Viral Pathogenesis Laboratory (VPL), and research fellow Kizzmekia Corbett dropped everything and began using this mRNA platform to develop a vaccine for the illness that would become known as COVID-19.”

In early March 2020, at a White House roundtable to discuss treatments for the coronavirus that “was spreading globally and killing Americans,” CNN reported that Moderna’s Stéphane Bancel caught the ear of President Trump by declaring that he was “very proud to be working with the US government and to already have sent, in only 42 days from the sequence of the virus, our vaccine to Dr. Fauci’s team at the NIH.” Bancel vowed he needed only “a few months” to start phase two of a three-part clinical trial of the sort that typifies vaccine development. Indeed, his declaration of speed was significant. Yet, corroborating what we’ve repeated—that unknowing individuals compelled to be injected with the deadly jabs remain part of a massive experiment—CNN added, “The entire [vaccine development] process often takes more than a decade.”

Wasting no time, the FDA approved Moderna’s mRNA product for trial the day after the roundtable, despite the fact the ten-year-old company had never brought a product to market or managed to get any of its roughly nine vaccine candidates approved for use by the FDA. A month and a half later, on April 16, 2020, Moderna received more government support for its COVID-19 vaccine when the federal Biomedical Advanced Research and Development Authority (BARDA) awarded Moderna up to $483 million to accelerate the development and manufacture of the experimental jab. Before COVID hit, Moderna had been working on mRNA technology with the US Defense Department’s Advanced Research Projects Agency (DARPA) for nearly a decade.

Further email batches from the NIH to ICAN reveal that, very early in the pandemic, the agency dismissed potential alternate treatments for COVID-19 and downplayed concerns about vaccine-enhanced illnesses. Of course, this makes sense when recognizing that there are two patents related to the development of Moderna’s mRNA-1273 that contain the same six individuals from the NIAID, including Dr. Barney Graham and Kizzmekia Corbett. ICAN reported that each inventor on the patent stands to receive a personal payment of up to $150k annually from the sales of mRNA-1273, and the NIAID stands to earn millions of dollars in revenue from the sale as well.

The latest nail in the coffin of this corrupt scheme using taxpayer money and deadly experiments on American citizens comes upon learning from ICAN’s latest report that Bill Gates had been involved in scheming about mRNA vaccines even before the pandemic began. ICAN remarked that the batch contained a “very interesting email in which a Bill & Melinda Gates Foundation (BMGF) official introduces Graham at NIH to Ugur Sahin, CEO of BioNTech on February 2, 2020″—just 13 days after the first case of SARS-CoV-2 was found in the US and before the WHO declared a pandemic. ICAN added, “we know the Gates Foundation bought shares in BioNTech back in September 2019 so it is interesting to see it actively making connections for BioNTech so quickly.”

Another email in the same batch shows that as the stock market plunged, Graham—who served on the WHO’s R&D Blueprint focused on COVID-19 viruses alongside Peter Daszak, four members of BMGF, and others—remarked about attempting to “calm things down” and help people “understand the market sentiment of the vaccines industry towards COVID-19 vaccines.” Thank God for ICAN, who has vowed to continue to report on the Graham emails as more batches are sent to them. ICAN reminded:

“Both these incidences show how the NIH acts just like a for-profit corporation with a vested interest in forming partnerships and worrying about financial markets—perhaps because the agency and many of its employees stand to profit from the success of the vaccines they develop, just like Graham did from the Moderna vaccine.”